Suppr超能文献

加拿大高血压控制的起伏:关键因素与经验教训

Ups and downs of hypertension control in Canada: critical factors and lessons learned.

作者信息

Campbell Norm Rc, Padwal Raj, Tsuyuki Ross T, Leung Alexander A, Bell Alan, Kaczorowski Janusz, Tobe Sheldon W

机构信息

Department of Medicine University of Calgary Calgary Canada Department of Medicine, University of Calgary, Calgary, Canada.

Department of Medicine University of Alberta Edmonton Canada Department of Medicine, University of Alberta, Edmonton, Canada.

出版信息

Rev Panam Salud Publica. 2022 Sep 2;46:e141. doi: 10.26633/RPSP.2022.141. eCollection 2022.

Abstract

As the leading risk for death, population control of increased blood pressure represents a major challenge for all countries of the Americas. In the early 1990's, Canada had a hypertension control rate of 13%. The control rate increased to 68% in 2010, accompanied by a sharp decline in cardiovascular disease. The unprecedented improvement in hypertension control started around the year 2000 when a comprehensive program to implement annually updated hypertension treatment recommendations started. The program included a comprehensive monitoring system for hypertension control. After 2011, there was a marked decrease in emphasis on implementation and evaluation and the hypertension control rate declined, driven by a reduction in control in women from 69% to 49%. A coalition of health and scientific organizations formed in 2011 with a priority to develop advocacy positions for dietary policies to prevent and control hypertension. By 2015, the positions were adopted by most federal political parties, but implementation has been slow. This manuscript reviews key success factors and learnings. Some key success factors included having broad representation on the program steering committee, multidisciplinary engagement with substantive primary care involvement, unbiased up to date credible recommendations, development and active adaptation of education resources based on field experience, extensive implementation of primary care resources, annual review of the program and hypertension indicators and developing and emphasizing the few interventions important for hypertension control. Learnings included the need for having strong national and provincial government engagement and support, and retaining primary care organizations and clinicians in the implementation and evaluation.

摘要

作为主要的死亡风险因素,控制血压升高对美洲所有国家来说都是一项重大挑战。在20世纪90年代初,加拿大的高血压控制率为13%。到2010年,控制率提高到68%,同时心血管疾病大幅下降。高血压控制方面前所未有的改善始于2000年左右,当时启动了一项全面计划,以实施每年更新的高血压治疗建议。该计划包括一个高血压控制综合监测系统。2011年之后,对实施和评估的重视程度显著下降,高血压控制率也随之下降,原因是女性的控制率从69%降至49%。2011年,一个由健康和科学组织组成的联盟成立,其优先事项是制定预防和控制高血压饮食政策的宣传立场。到2015年,大多数联邦政党都采纳了这些立场,但实施进展缓慢。本手稿回顾了关键的成功因素和经验教训。一些关键的成功因素包括在项目指导委员会中有广泛的代表性、多学科参与且有实质性的初级保健参与、公正且最新的可信建议、根据实地经验开发并积极调整教育资源、广泛实施初级保健资源、对项目和高血压指标进行年度审查,以及制定并强调对高血压控制重要的少数干预措施。经验教训包括需要国家和省级政府大力参与和支持,以及在实施和评估过程中留住初级保健组织和临床医生。

相似文献

1
Ups and downs of hypertension control in Canada: critical factors and lessons learned.
Rev Panam Salud Publica. 2022 Sep 2;46:e141. doi: 10.26633/RPSP.2022.141. eCollection 2022.
2
[Tuberculosis in Asia].
Kekkaku. 2002 Oct;77(10):693-7.
4
The Canadian effort to prevent and control hypertension: can other countries adopt Canadian strategies?
Curr Opin Cardiol. 2010 Jul;25(4):366-72. doi: 10.1097/HCO.0b013e32833a3632.
6
Implementation of recommendations on hypertension: the Canadian Hypertension Education Program.
Can J Cardiol. 2006 May 15;22(7):595-8. doi: 10.1016/s0828-282x(06)70281-1.
8
Risk management frameworks for human health and environmental risks.
J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. doi: 10.1080/10937400390208608.

引用本文的文献

1
Misclassification of Hypertension Status According to Office Blood Pressure vs 24-Hour Ambulatory Blood Pressure Monitoring.
CJC Open. 2025 Jan 11;7(4):508-515. doi: 10.1016/j.cjco.2025.01.007. eCollection 2025 Apr.
2
Patient-Physician Language Concordance and Cardiovascular Outcomes Among Patients With Hypertension.
JAMA Netw Open. 2025 Feb 3;8(2):e2460551. doi: 10.1001/jamanetworkopen.2024.60551.
5
Validity of Home Blood Pressure Devices Sold in Canada.
CJC Open. 2023 Oct 6;6(1):54-56. doi: 10.1016/j.cjco.2023.10.001. eCollection 2024 Jan.
6
HEARTS in the Americas: Targeting Health System Change to Improve Population Hypertension Control.
Curr Hypertens Rep. 2024 Apr;26(4):141-156. doi: 10.1007/s11906-023-01286-w. Epub 2023 Dec 2.
7
[Not Available].
CMAJ. 2023 Mar 20;195(11):E416-E425. doi: 10.1503/cmaj.220673-f.

本文引用的文献

2
Epidemiology of Resistant Hypertension in Canada.
Can J Cardiol. 2022 May;38(5):681-687. doi: 10.1016/j.cjca.2022.01.029. Epub 2022 Feb 3.
3
Refocusing on hypertension control in Canada.
CMAJ. 2021 Jun 7;193(23):E854-E855. doi: 10.1503/cmaj.210140.
4
Change of education strategy associated with slippage in Canadian hypertension awareness treatment and control rates.
J Hum Hypertens. 2021 Nov;35(11):1054-1056. doi: 10.1038/s41371-021-00519-2. Epub 2021 Mar 25.
6
Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018.
JAMA. 2020 Sep 22;324(12):1190-1200. doi: 10.1001/jama.2020.14545.
7
Worsening Hypertension Awareness, Treatment, and Control Rates in Canadian Women Between 2007 and 2017.
Can J Cardiol. 2020 May;36(5):732-739. doi: 10.1016/j.cjca.2020.02.092. Epub 2020 Apr 13.
8
A New Algorithm for the Diagnosis of Hypertension in Canada.
Can J Cardiol. 2015 May;31(5):620-30. doi: 10.1016/j.cjca.2015.02.014. Epub 2015 Feb 19.
9
The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States.
Can J Cardiol. 2013 May;29(5):598-605. doi: 10.1016/j.cjca.2012.12.004. Epub 2013 Mar 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验